|
|
||||||||||
|
Click on image to view larger version.
Figure 2 Composite six-month end point of death or myocardial (re-) infarction event rates for the glycoprotein IIb/IIIa interventional trials. *EPISTENT trial groups compared with reference group of Placebo + Stent. Abbreviations as in Figure 1.
|
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |